Literature DB >> 26678441

Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.

J Yang1, Q Li2, X Yang3, M Li4.   

Abstract

OBJECTIVE: Prolactin (PRL) is known to aid effector B cells and augment autoimmunity, but the role of PRL in systemic lupus erythematosus (SLE) is not fully elucidated. The aim of this study was to determine the correlation between the serum levels of PRL and autoantibody production in SLE.
METHODS: Blood levels of PRL, anti-double-stranded DNA (ds-DNA) antibody, immunoglobulin M (IgM) and immunoglobulin G (IgG) were determined in samples from 30 adult patients with SLE and 25 healthy controls. The relationships between the serum level of PRL and SLE disease activity, as well as the titres of the ds-DNA antibody, IgM and IgG were determined.
RESULTS: The serum level of PRL was higher in the SLE patients than in the healthy controls. PRL concentration increased during SLE flares-ups and decreased following disease remission. There was a positive correlation between the PRL concentration and serum levels of IgM, IgG and ds-DNA antibody titre.
CONCLUSION: These data suggest that the serum level of PRL was closely related to the antibody production and disease activity of SLE patients. PRL concentration was dramatically reduced upon the remission of disease activity, indicating that PRL levels might be a promising predictor of SLE disease severity.
© The Author(s) 2015.

Entities:  

Keywords:  Systemic lupus erythematosus; antibody; prolactin

Mesh:

Substances:

Year:  2015        PMID: 26678441     DOI: 10.1177/0961203315622276

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

1.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

2.  Proteinuria and serum creatinine after 12 months of treatment for lupus nephritis as predictors of long-term renal outcome: a case-control study.

Authors:  Fernanda Nogueira Holanda Ferreira Braga; Marta Maria das Chagas Medeiros; Antonio Brazil Viana Junior; Matheus Eugênio de Sousa Lima; Levi Coelho Maia Barros; Marcelo Ximenes Pontes; Allysson Wosley de Sousa Lima; Paula Frassinetti Castelo Branco Camurça Fernandes
Journal:  Adv Rheumatol       Date:  2022-01-04

3.  Prolactin Rescues Immature B Cells from Apoptosis-Induced BCR-Aggregation through STAT3, Bcl2a1a, Bcl2l2, and Birc5 in Lupus-Prone MRL/lpr Mice.

Authors:  Rocio Flores-Fernández; Angélica Aponte-López; Mayra C Suárez-Arriaga; Patricia Gorocica-Rosete; Alberto Pizaña-Venegas; Luis Chávez-Sanchéz; Francico Blanco-Favela; Ezequiel M Fuentes-Pananá; Adriana K Chávez-Rueda
Journal:  Cells       Date:  2021-02-04       Impact factor: 6.600

4.  A Survey on Sleep Disorders and Related Hormones in Patients with Newly Diagnosed Systemic Lupus Erythematosus.

Authors:  Maryam Sahebari; Sahar Ravanshad; Yalda Ravanshad; Fariborz Rezaeitalab; Houshang Rafat Panah Bayegi; Hadi Asadpour; Seyed Alireza Javadinia; Zahra Rezaieyazdi
Journal:  Mediterr J Rheumatol       Date:  2021-06-30

5.  Prolactin Rescues Immature B-Cells from Apoptosis Induced by B-Cell Receptor Cross-Linking.

Authors:  Rocio Flores-Fernández; Francisco Blanco-Favela; Ezequiel M Fuentes-Pananá; Luis Chávez-Sánchez; Patricia Gorocica-Rosete; Alberto Pizaña-Venegas; Adriana Karina Chávez-Rueda
Journal:  J Immunol Res       Date:  2016-05-24       Impact factor: 4.818

Review 6.  The role of inflammation in the development of epilepsy.

Authors:  Amna Rana; Alberto E Musto
Journal:  J Neuroinflammation       Date:  2018-05-15       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.